thalidomide has been researched along with dimethylnitrosamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morgan, M; Stirling, D; Teo, S; Thomas, S | 1 |
| Chiu, YT; Chong, LW; Hsu, YC; Huang, YT; Yang, KC | 1 |
2 other study(ies) available for thalidomide and dimethylnitrosamine
| Article | Year |
|---|---|
Assessment of the in vitro and in vivo genotoxicity of Thalomid (thalidomide).
Topics: Animals; Bone Marrow Cells; Cell Survival; CHO Cells; Cricetinae; Dimethylnitrosamine; Escherichia coli; Ethyl Methanesulfonate; Female; Male; Mice; Micronucleus Tests; Mutagenesis; Mutagenicity Tests; Mutagens; Salmonella typhimurium; Thalidomide | 2000 |
Anti-fibrotic effects of thalidomide on hepatic stellate cells and dimethylnitrosamine-intoxicated rats.
Topics: Actins; Animals; Collagen; Dimethylnitrosamine; Fibrosis; I-kappa B Proteins; Immunosuppressive Agents; Liver; Liver Cirrhosis, Experimental; Muscle, Smooth; NF-kappa B; NF-KappaB Inhibitor alpha; Rats; Thalidomide; Transforming Growth Factor beta; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2006 |